James M. Mock - 05 Dec 2024 Form 4 Insider Report for Moderna, Inc. (MRNA)

Role
Chief Financial Officer
Signature
/s/ Brian Sandstrom, As Attorney-in-Fact
Issuer symbol
MRNA
Transactions as of
05 Dec 2024
Transactions value $
$0
Form type
4
Filing time
06 Dec 2024, 16:55:07 UTC
Previous filing
02 Dec 2024
Next filing
06 Jan 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRNA Restricted Stock Units Award $0 +189K $0.00 189K 05 Dec 2024 Common Stock 189K $0.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to this restricted stock unit award will vest on December 5, 2025, with the remainder vesting in twelve (12) equal quarterly installments thereafter.